Skip to main content
SpringerLink
Log in

The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Hyperhidrosis is a chronic condition characterized by excessive sweating. Recent studies report that it affects approximately 2.8% of the population and typically begins during adolescence. Gustatory sweating usually occurs after parotid gland injury or surgery, and both disorders can be debilitating for those who are affected. Both diseases respond very well to botulinum toxin therapy and this article will review the use of botulinum toxins, including the serotypes used, dosing, and complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baumann LS (2003) Systemic adverse events after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhi-drosis.Arch. Dermatol. 139, 226–227.

    Article  PubMed  Google Scholar 

  • Beerens AJF and GB Snow (2002) Botulinum toxin A in the treatment of patients with Frey syndrome.Br. J. Surg. 89, 116–119.

    Article  CAS  PubMed  Google Scholar 

  • Bjerkhoel A and O Trobbe (1997) Frey’s syndrome: treatment with botulinum toxin.J. Laryngol. Otol. 111(9), 839–844.

    Article  CAS  PubMed  Google Scholar 

  • Bushara Ko, DM Park, JC Jones and HS Schutta (1996) Botulinum toxin — a possible new treatment for axillary hyperhidrosis.Clin. Exp. Dermatol. 21(4), 276–278.

    Article  CAS  PubMed  Google Scholar 

  • Dressler D, F Adib Saberi and R Benecke (2002) Botulinum toxin type B for treatment of axillary hyperhidrosis.J. Neurol. 249, 1729–1732.

    Article  CAS  PubMed  Google Scholar 

  • Eckardt A and C Kuettner (2003) Treatment of gustatory sweating (Frey’s Syndrome) with botulinum toxin A.Head Neck 25, 624–628.

    Article  PubMed  Google Scholar 

  • Glaser DA, N Solish, MK Naumann, H Hamm, NJ Lowe, A Benohanian and JW Kowalski (2004) Botulinum toxin type A improves occupational impairment associated with primary axillary hyperhidrosis and results in high levels of satisfaction with treatment. Poster-abstract at Summer American Academy Dermatology meeting. New York.

  • Glaser DA, JW Kowalski, Y Weng, A Ravel, S Daggett, M Nordquist and N Eadie (2005) Effect of repeated botulinum toxin type-A treatment on quality of life and functioning in patients with severe primary axillary hyperhidrosis: results from 2 years longitudinal data. Poster 43, Am. Acad. Dermatol. Annual Summer Meeting Chicago.

  • Glaser DA, JW Kowalski, N Eadie, N Solish, A Ravelo, Y Weng and PR Reese (2006) Hyperhidrosis disease severity scale (HDSS): validty and reliability results from three studies. (in press).

  • Guntinas-Lichius O (2002) Increased botulinum toxin type A dosage is more effective in patients with Frey’s Syndrome.Laryngoscope 112, 746–749.

    Article  CAS  PubMed  Google Scholar 

  • Hecht MJ, F Birklein and M Winterholler (2004) Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.Arch. Dermatol. Res. 295(8-9), 318–319.

    Article  PubMed  Google Scholar 

  • Hornberger J, K Grimes, M Naumann, DA Glaser, NJ Lowe, H Nayer, S Ahn and LP Stolman (2004) Multi-specialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis.J. Am. Acad. Dermatol. 51, 274–286.

    Article  PubMed  Google Scholar 

  • Kavanuagh GM, C Oh and K Shams (2004) Botox delivery by iontophoresis.Br. J. Dermatol. 151(5), 1093–1095.

    Article  Google Scholar 

  • Kyrmizakis DE, A Pangalos, CE Papadakis, J Logothetis, NJ Maroudias and ES Helidonis (2004) The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes.J. Oral. Maxillofac. Surg. 62(7), 840–844.

    Article  PubMed  Google Scholar 

  • Laccourreye O, L Muscatelo, B Bonan, C Naude and D Bransu (1998) Botulinum toxin type A for Frey’s syndrome: apreliminary prospective study.Ann. Oto. Rhino. Laryngol. 107, 52–55.

    Article  CAS  Google Scholar 

  • Laskawi R, C Drobik and C Schonebeck (1998) Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey’s Syndrome).Saryngoscope 108, 381–384.

    Article  CAS  Google Scholar 

  • Naumann M and NJ Lowe (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.BMJ 323, 596–599.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Naumann M, M Zellner, K Toyka and K Reiners (1997) Treatment of gustatory sweating with botulinum toxin.Ann. Neurol. 42, 973–975.

    Article  CAS  PubMed  Google Scholar 

  • Naumann MK, H Hamm and NJ Lowe (2002) Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.Br. J. Dermatol. 147 (6), 1218–1226.

    Article  CAS  PubMed  Google Scholar 

  • Sato K, WH Kang, K Saga and KT Sato (1989) Biology of sweat glands and their disorders. Normal sweat gland function.J. Am. Acad. Dermatol. 20, 537–561.

    Article  CAS  PubMed  Google Scholar 

  • Strutton DR, JW Kowalski, DA Glaser and PE Stang (2004) US Prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.J. Am. Acad. Dermatol. 51(2), 241–248.

    Article  PubMed  Google Scholar 

  • Swartling C, H Naver and M Lindberg (2001) Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.Eur. J. Neurol. 8, 247–252.

    Article  CAS  PubMed  Google Scholar 

  • Tugnoli V, R Marchese Ragona, R Eleopra, D De Grandis and C Montecucco (2001) Treatment of Frey syndrome with botulinum toxin type F.Arch. Otolaryngol. Head Neck Surg. 127(3), 339–340.

    Article  CAS  PubMed  Google Scholar 

  • Vadoud-Seyedi J (2004) Treatment of plantar hyperhidrosis with botulinum toxin.Int. J. Dermatol. 43(12), 969–971.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Saint Louis University School of Medicine, 63104, St Louis, MO, USA

    Dee Anna Glaser

Authors
  1. Dee Anna Glaser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dee Anna Glaser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glaser, D.A. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome. neurotox res 9, 173–178 (2006). https://doi.org/10.1007/BF03033936

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033936

Keywords

Search

Navigation